pharma · Hereditary Angioedema · Diabetic Macular Edema · KALV
Kalvista Pharmaceuticals (Ireland)
Kalvista Pharmaceuticals (Ireland) Limited
Kalvista Pharmaceuticals (Ireland) trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Framingham, USA HQ
279 Employees
Public company Type
KALV · NYSE Ticker
Company details
- Status
- Public
- HQ
- Framingham, USA
- Employees
- 279
- Programs
- 8
- Drugs
- 6
- Patents
- 24
Kalvista Pharmaceuticals (Ireland) clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Kalvista Pharmaceuticals (Ireland) programs — each row shows trial ID, program name, phase, status, and indication.
Kalvista Pharmaceuticals (Ireland) trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Kalvista Pharmaceuticals (Ireland).
-
Placebo — Phase 3
Clinical update -
KVD824 Prototype 1 modified-release tablet — Phase 1
Clinical update -
KVD001 Injection — Phase 2
Clinical update -
KVD900 150 mg — Phase 3
Clinical update -
KVD900 600 mg — Phase 3
Clinical update -
KVD824 — Phase 2
Clinical update -
KVD900 — Phase 2
Clinical update -
KVD824 — Phase 1
Clinical update